InvestorsHub Logo

exwannabe

11/24/15 9:07 PM

#243642 RE: ku #243639

He got us the fast track and has told us that I get approval for you in 2017.


Did he really state he will get an approval in 2017?

If so, he he clearly not being truthful, and just making money by selling his name (and ex position).

They certainly MIGHT get an approval by then, but he has no way to know this. And there is nothing at all he could do to insure it.

Without an early halt, and with good data, the approval would likely be in 2018. And I am morally certain that he knows this.

Protector

11/25/15 6:28 AM

#243654 RE: ku #243639

ku, when PPHM files for the Breast PII/PIII combination then all that PI/PII stuff will be in the file.

The PII Breast results were good and that has been posted in the past. Those trials contained Complete Responses and that was public information. Many spread the doom that PPHM forgot about breast cancer because ...this and that...but now it is clear they just waited for the strategic moment to activate it and push it to the next level, a PIII.

PPHM is of course today in a completely different situation where they can sponsor such trials and where more data from other trials such as 2nd ln NSCLC showed the synergy with Docetaxel.